Brain ischemia changes the long term response to antidepressant drugs in mice

Behavioural Brain Research

Volumn 219, Issue 2, 2011, Pages 367-372

  Deplanque, Dominique ^a   Venna, Venugopal Reddy ^a   Bordet, Régis ^a  

^a UNIV LILLE   (France)

Author keywords

Antidepressant drugs; Behaviour; Brain ischemia; Depression; Forced Swim Test

Indexed keywords

FLUVOXAMINE; IMIPRAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BRAIN ISCHEMIA; CLIMBING; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; FORCED SWIMMING TEST; HISTOPATHOLOGY; IMMOBILIZATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; RESPONSE TIME; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; SEROTONIN UPTAKE INHIBITORS; SWIMMING;

EID: 79952708716     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.01.003     Document Type: Article

References (36)

1. Salaycik K.J., Kelly-Hayes M., Beiser A., Nguyen A.H., Brady S.M., Kase C.S., et al. Depressive symptoms and risk of stroke. The Framingham Study. Stroke 2007, 38:16-21.
2. Lee H.C., Lin H.C., Tsai S.Y. Severely depressed young patients have over five times increased risk for stroke: a 5-year follow-up study. Biol Psychiatry 2008, 64:912-915.
3. Robinson R.G. Post-stroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003, 54:376-387.
4. Starkstein S.E., Mizrahi R., Power B.D. Antidepressant therapy in post-stroke depression. Expert Opin Pharmacother 2008, 9:1291-1298.
5. Provinciali L., Paolucci S., Torta R., Toso V., Gobbi B., Gandolfo C. Depression after first-ever ischemic stroke: the prognostic role of neuroanatomic subtypes in clinical practice. Cerebrovasc Dis 2008, 26:592-599.
6. Teodorczuk A., O'Brien J.T., Firbank M.J., Pantoni L., Poggesi A., Erkinjuntti T., et al. White matter changes and late-life depressive symptoms. Br J Psychiatry 2007, 191:212-217.
7. Steffens D.C., Chung H., Krishnan K.R., Longstreth W.T., Carlson M., Burke G.L. Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovacular Health Study. Stroke 2008, 39:857-862.
8. Chen Y., Guo J.J., Zhan S., Patel N.C. Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Ann Pharmacother 2006, 40:2115-2122.
9. Hackett M.L., Anderson C.S., House A., Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008, 4:CD003437.
10. Ginsberg M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008, 55:363-389.
11. DeVries A., Nelson R.J., Traystman R.J., Hurn P.D. Cognitive behavioral assessment in experimental stroke research: will it prove useful?. Neurosci Behav Rev 2001, 25:325-342.
12. Bantsiele G.B., Bentué-Ferrer D., Amiot N., Allain H., Bourin M., Reymann J.M. Does rat global cerebral ischemia serve as an appropriate model to study emotional disturbances?. Fund Clin Pharmacol 2004, 18:685-692.
13. Winter B., Juckel G., Viktorov I., Katchanov J., Gietz A., Sohr R., et al. Anxious and hyperactive phenotype following brief ischemic episode in mice. Biol Psychiatry 2005, 57:1166-1175.
14. Bantsiele G.B., Bentué-Ferrer D., Saïkali S., Laviolle B., Bourin M., Reymann J.M. Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances. Behav Brain Res 2009, 201:265-271.
15. Deplanque D., Gelé P., Pétrault O., Six I., Furman C., Bouly M., et al. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 2003, 23:6264-6271.
16. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
17. Bourin M., Fiocco A.J., Clenet F. How valuable are animal models in defining antidepressant activity. Hum Psychopharmacol Clin Exp 2001, 16:9-21.
18. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17:472-476.
19. David D.J., Renard C.E., Jolliet P., Hascoët M., Bourin M. Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology 2003, 166:373-382.
20. Venna V.R., Deplanque D., Allet C., Belarbi K., Hamdane M., Bordet R. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009, 34:199-211.
21. 1B receptors in old mice. Psychopharmacology 2001, 153:443-449.
22. Block F. Global ischemia and behavioral deficits. Prog Neurobiol 1999, 58:279-295.
23. Robinson R.G. Differential behavioral and biochemical effects of right and left hemispheric cerebral infarction in the rat. Science 1979, 205:707-710.
24. Araki H., Hino N., Karasawa Y., Kawasaki H., Gomita Y. Effect of dopamine blockers on cerebral ischemia-induced hyperactivity in gerbils. Physiol Behav 1999, 66:263-268.
25. Mitsuyo T., Adachi N., Yorozuya T., Tabo E., Nagaro T., Arai T. Facilitation of ischemia-induced release of dopamine and neuronal damage by dexamethasone in the rat striatum. Eur J Pharmacol 2003, 465:267-274.
26. Milot M., Plamandon H. Time-dependent effects of global ischemia on anxiety, locomotion, and habituation in rats. Behav Brain Res 2009, 200:173-180.
27. Connolly E.S., Winfree C.J., Stern D.M., Solomon R.A., Pinsky D.J. Procedural and strain-related variables significantly affect outcome in a murine model of focal cerebral ischemia. Neurosurgery 1996, 38:523-531.
28. Aben I., Verhey F., Honig A., Lodder J., Lousberg R., Maes M. Research into the specificity of depression after stroke: a review on an unresolved problem. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:671-689.
29. Borsini F. Role of the serotoninergic system in the forced swimming test. Neurosci Behav Rev 1995, 19:377-395.
30. Yan B., Wang D.Y., Xing D.M., Ding Y., Wang R.F., Lei F., et al. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol Biochem Behav 2004, 78:319-325.
31. Kato M., Iwata H., Okamoto M., Ishii T., Narita H. Focal cerebral ischemia-induced escape deficit in rats is ameliorated by a reversible inhibitor of monoamine oxidase-A: implications for a novel animal model of post-stroke depression. Biol Pharm Bull 2000, 23:406-410.
32. Yan X.B., Wang S.S., Hou H.L., Ji R., Zhou J.N. Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav Brain Res 2007, 177:282-289.
33. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
34. Wang S.H., Zhang Z.J., Guo Y.J., Sui Y.X., Sun Y. Involvement of serotonin neurotransmission in hippocampal neurogenesis and behavioral responses in a rat model of post-stroke depression. Pharmacol Biochem Behav 2010, 95:129-137.
35. Craft T.K.S., DeVries A.C. Role of IL-1 in poststroke depressive-like behavior in mice. Biol Psychiatry 2006, 60:812-818.
36. Rampello L., Battaglia G., Raffaele R., Vecchio I., Alvano A. Is it safe to use antidepressants after stroke?. Expert Opin Drug Saf 2005, 4:885-897.